Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
- 1 May 2008
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (5), 812-819
- https://doi.org/10.1111/j.1538-7836.2008.02938.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tumor cell–associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell–dependent and–independent mechanismsBlood, 2007
- Platelet glycoprotein Ibα supports experimental lung metastasisProceedings of the National Academy of Sciences, 2007
- Factor XIII (FXIII) and angiogenesisJournal of Thrombosis and Haemostasis, 2006
- Factor XIII and the clotting of fibrinogen: from basic research to medicineJournal of Thrombosis and Haemostasis, 2005
- Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cellsBlood, 2005
- Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasisBlood, 2004
- Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454Thrombosis and Haemostasis, 2003
- Fibronectin in malignancySeminars in Cancer Biology, 2002
- Role of Fibrin Matrix in AngiogenesisAnnals of the New York Academy of Sciences, 2001
- Vitronectin is a substrate for transglutaminasesBiochemical and Biophysical Research Communications, 1988